Robert M. Nordgren has 35 years’ experience in the field of Veterinary Vaccine and Bio-pharmaceutical discovery, Development, Registration and post launch support.

Bob has completed a PhD and Post Doc with the college of Vet Medicine at Texas A&M. This was followed by 32 years with major international  pharmaceutical companies including Head of Avian Development with Solvay Animal Health, Head of R&D for Boehringer Animal Health and the 16 years at Merial as Head of Vaccine R&D and then 3 years of helping and leading formation of a number of start-up Vet Pharma/Vaccines companies.

Bob currently is the Head of Research and Development at Curtiss Healthcare, a Managing Partner with The Yield Lab, and serves as Chair or Board member of a number of other start-up firms. Over this career, Bob has led teams leading to the licensure of over 80 unique products, many of them first in class.